By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • Cancer drug shows potential as treatment for muscular dystrophy – The University of British Columbia

Cancer drug shows potential as treatment for muscular dystrophy – The University of British Columbia

Saturday, 2 July, 2022

Cancer drug shows potential as treatment for muscular dystrophy – The University of British Columbia

Duchenne muscular dystrophy (DMD) is a severe genetic disorder that leads to progressive muscle weakness.

Forward by our Assistant Editor – Research from UBC’s School of Biomedical Engineering have found out that a cancer drug called a colony-stimulating factor 1 receptor (CSF1R) inhibitor, may treat people with muscular dystrophy. There are many forms of muscular dystrophy, a severe genetic disorder which leads to muscle weakness and loss, which is usually diagnosed when a child is 3 to 6 years old. This illness decreases life expectancies by impacting heart and lung function. There is no current cure. However, CSF1R is slowing down the deterioration of the disease and helping muscular dystrophy patients keep their mobility for longer.
By Khaleel Chima - Assistant Editor - Lead Roving Reporter – Ability Today

Cancer drug shows potential as treatment for muscular dystrophy - The University of British Columbia

Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy.
The researchers found that the drug — known as a colony-stimulating factor 1 receptor (CSF1R) inhibitor — helped slow the progress of Duchenne muscular dystrophy in mice by increasing the resiliency of muscle fibres.
The findings were published today in Science Translational Medicine.
Read more at: https://news.ubc.ca/2022/06/29/cancer-drug-shows-potential-as-treatment-for-muscular-dystrophy/

Categories :
  • Latest Headlines
  • Muscular Dystrophy
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved